Cardiorenal syndrome;Síndrome cardiorrenal

Revista de la Federacion Argentina de Cardiologia

Volumn 42, Issue 2, 2013, Pages 88-95

  Márquez, Lilia Luz Lobo ^a   de la Serna, Fernando ^a  

^a Departamento de ecografía Instituto de Cardiología SRL   (Argentina)

Author keywords

Cardiorenal syndrome; Cystatin C; N GAL

Indexed keywords

ADRENERGIC SYSTEM; ARTICLE; CARDIORENAL SYNDROME; HEART FAILURE; HEART FUNCTION; HOMEOSTASIS; HUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RETENTION; WATER RETENTION;

EID: 84879640619     PISSN: 0326646X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Viswanathan G, Gilbert S. The cardiorenal syndrome: making the connection. Int J Nephrol 2010; 2011: 283137. doi: 10.4061/2011/283137
2. Wencker D. Acute cardio-renal syndrome: progression from congestive heart failure to congestive kidney failure. Curr Heart Fail Rep 2007; 4: 134-38.
3. Cardiovascular disease, 2008. http//www.americanheart.org
4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
5. Cruz DN, Bagshaw SM. Heart kidney interaction: Epidemiology of cardiorenal syndromes. Int J Nephrology 2010; 2011: 351291
6. Mentz RJ, Lewis EF. Epidemiology of cardiorenal syndrome. Cardiol Clin 2011; 29: 301-314.
7. Ahmed A, Campbell RC. Epidemiology of chronic kidney disease in heart failure. Heart Failure Clin 2008; 4: 387-399.
8. Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 62-72.
9. Matsushita K, Selvin E, Bash LD, et al. Risk implications of the new Epidemiology Collaboration (CKD-API) Equation as compared with the MDRD study equation for estimated GFR: The Aterosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010; 55: 648-659.
10. Juntesen TL, Peteresen H, Ekbom P, et al.: Albumin-to-creatinine ratio in random urine samples might replace 24-h collection in screening for microand macroalbuminuria in pregnant woman with type I diabetes. Diabetes care 2006; 29: 924-925.
11. Hyun An J, Min Cho Y, Gon Yu H, et al. The Clinical Characteristics of Normoalbuminuric Renal Insufficiency in Korean Type 2 Diabetic Patients: A Possible Early Stage Renal Complication. J Korean Med Sci 2009; 24 (Suppl 1): S75-81.
12. Valmadrid CT, Klein R, Moss SE, et al: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100.
13. Viazzi F, Leoncini G, Conti N, et al. Microalbuminuria is a predictor of chronic renal insufficiency in patients without DM and with hypertension. The MAGIC study. Clin J Am Soc Nephrol 2010; 5: 1099-1106.
14. Fonarow GC. For the ADHERE A Cientific Advisory Committee. Heart Fail Rev 2004; 9: 179-185.
15. Heywood JT, Fonarow GC, Costanzo MR, et al for the ADHERE Scientific Committee and Investigators. High prevalence of renal dysfunction and its impact on outcome in 118.465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Cardiac Fail 2007; 13: 422-430.
16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
17. McCullough PA. Why is chronic kidney disease the "spoiler" from cardiovascular outcomes?. J Am Coll Cardiol 2003; 41: 725-728.
18. MacDowall P, Kalra PA, O'Donoghue DJ, et al: Risk of morbidity from Lancet 1998; 352: 13-16.
19. Smilde TDJ, Hillege HI, Navis G, et al. Impaired renal function in patients with ischemic and non ischemic chronic heart failure: Association with neurohormonal activation and survival. Am Heart J 2004; 148: 165-172.
20. Lapman PG, Golduber GN, Le Jemtel TH. Heart Failure treatment and renal function. Am Heart J 2004; 147: 193-194.
21. Chadhan M, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults. The AusDiab kidney study. J Am Soc Nephrol 2003; 14: S131-138.
22. Saab G, Whaley-Connell A, Bombeck A, et al For the Kidney Early Evaluation Program Investigators. The association between Parathyroid Hormone levels and the Cardiorenal Metabolic Syndrome in non-diabetic chronic kidney disease. Cardiorenal Med 2011; 1: 123-130.
23. Chen J, Muntner P, Hamm LL, et al: The metabolic syndrome and chronic kidney disease in US adults. Ann Inter Med 2004; 140: 167-174.
24. Whaley-Connell A, Pavey BS, McCullough PA, et al For the KEEP investigators: Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Hypertens 2010; 12: 51-58.
25. Luk AOY, SO W-C, Ma RCW, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes. Diabetes Care 2008; 31: 2357-2361.
26. Khan NA, Ma I, Thompson CR, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 2006; 17: 244-253.
27. Udani SM, Koyner JL. The effects of heart failure on renal function. Cardiol Clin 2010; 28: 453-465.
28. Weiner DE, Krassilnikova M, Hocine T, et al. CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC Nephrol 2009;10:26-37
29. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-210
30. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678.
31. Ahmed A, Rich MW, Sanders PW, et al. Chronic kidney diseasse associates mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007; 99: 393-398.
32. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006; 47: 1987-1998.
33. Campbell RC, Sui X, Filippatos G, et al. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity matched study. Nephrol Dial Transplant 2009; 24: 186-193.
34. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628-1637.
35. Shlipak MG, Katz R, Kestenabum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009; 20: 2625-2630.
36. Dhingra R, Gaziano JM, Djoussé L. Chronic kidney disease and the risk of heart failure in men. Circ Heart Fail 2011; 4: 138-144.
37. Damman K, Jaarsma T, Voors AA, et al. Both inand out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009; 11: 847-854.
38. Lanfear DE, Peterson EL, Campbell J, et al. Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization. Am J Cardiol 2011; 107: 74-78.
39. Anderson J, Glynn LG, Newell J, et al. The impact of renal insufficiency and anaemia on survival in patients with cardiovascular diseases: a cohort study. BMC Cardiovasc Disorders 2009; 9: 51-60.
40. Tarng DC. Cardiorenal anemia syndrome in chronic kidney disease. J Chin Med Assoc 2007; 70: 424-9 (abstract PubMed).
41. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786.
42. Liang KV, Williams AW, Greene EN, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008; 36 (Suppl): S75-86.
43. Boerrigter G, Burnett JC. Cardiorenal syndrome in decompensated heart failure: Prognostic and therapeutic implications. Curr Heart Fail Rep 2004; 1: 113-120.
44. Endre ZH, Pickering JW. New markers of acute kidney injury: giant leaps and baby steps. Clin Biochem Rev 2011; 32: 121-124.
45. Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1257-1239.
46. Ronco C, McCullough P, Anker SD, et al For the Acute Dyalisis Quality Initiative (ADQI) consensu group. Cardio-renal syndromes: report from the consensus conference of the Acute Dyalysis Qualitive Initiative. Eur Heart J 2010; 31:703-711.
47. Aronson D, Mittleman MA, Burger AJ: Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 2004; 116: 466-473.
48. Owen TE, Hodge DO, Herges RM, et al.: Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006; 12: 257-262.
49. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart: el 11-64% de los pacientes con shock sefailure. J Am Coll Cardiol 2004; 43: 61-67
50. McCullough PA. Cardiorenal syndromes: pathophysiology to prevention. Int J Nephrol 2010; 2011: 762590. doi: 10.4061/2011/762590.
51. Damman K, Navis G, Voors AA, et al. Worsening renal function and prognosis in heart failure: Systematic review and meta-analysis. J Cardiac Fail 2007; 13: 599-608.
52. Damman K, Navis G, Smilde TDJ, et al.: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007; 9: 872-978.
53. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am heart J 2004; 147: 331-338.
54. Testani JM, Chen J, McCauley BD, et al. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265-272.
55. Krumholz HM, Chen YT, Vaccarino V, et al: Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure. Am J Cardiol 2000, 85: 1110-113.
56. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 1990; 39 (suppl 4): 10-24.
57. Cowie MR, Komajda M, Murray-Thomas T, et al. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heat failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006; 27: 1216-1222.
58. Bellomo R, Ronco C, Kolurt JA, et al. Acute Dialysis Quality Initiative workgropu; Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initative (ADQI) Group. Cir Care 2004; 8: R204-R212.
59. Hosfe EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73-R82.
60. Shirakabe A, Hata N, Kobayashi N, et al. Long-term prognosis impact after acute kidney injury in patients with acute heart failure. Evaluation of the RIFLE criterium. Int Heart J 2912; 53: 313-319.
61. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report on a initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11 (2): R31.
62. Metra M, Nodari S, Parrinello G, et al. Worsening renal function in patientes hospitalized for acute heart failure: clinical implications and prognostic significance. Eur J Heart Failure 2008; 10: 188-195.
63. Cauthen CA, Lipinski MJ, Abbate A, et al. Relation of blood urea nitrogen to long term mortality in patients with heart failure. Am J Cardiol 2008; 101: 1643-1647.
64. Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 2008; 1: 2-5.
65. Damman K, Voors AA, Navis G, et al. Current and novel renal biomarkers in heart failure. Heart Fail Rev 2012; 17: 241-250.
66. Coll E, Botey A, Alvarez L, et al. Serum Cystatine C as a new marker for nor invasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidn Dis 2000; 36: 29-34.
67. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatine C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
68. Madero M, Sarnak MJ. Association of cystatine C with adverse outcomes. Curr Opin Nephrol Hypertens 2009; 18: 258-263.
69. Zappitelli M, Washbum KK, Arikan AA, et al. Urine neutrophil gelatinase associated lipocalin is an early marker of acute kisney injury in critically ill children: a prospective cohort study. Crit Care 2007; 11 (4): R84.
70. Ronco C. N-GAL: Diagnosing AKI as soon as possible. Crit Care 2007; 11: 173-174.
71. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010; 4: 265-280.
72. Maisel AS, Mueller C, Fitzgerald R, et al. Prognostic utility of plasma gelatinase-associated lipocalin in patients with acute heart failure: Th NGAL EvaLuation Along with B-type NaTriuretic Ppetide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail 2011; 13: 846-851.
73. Liangos O, Perianayagam MR, Vaidya VS, et al. Urinary N-acetyl-beta-(d)glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 904-912.
74. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, et al. Tubular damage in chroni systolic heart failure is associated with reduced survial independent of glomerular fitration rate. Heart 2010; 96: 1297-1302.
75. Hebert K, Dias A, Delgado MC, et al. Epidemiology and survival of the five stages of chronic disease in a systolic heart failure population. Eur J Heart Fail 2010; 12: 861-865.
76. Legrand M, Mik EG, Johannes T, et al. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008; 14: 502-516.
77. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data 2007 annual data report. Am J Kidney Dis 2008; 51 Suppl 1: S1-320.
78. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
79. Thierer J. Insuficiencia cardíaca, disfunción renal y anemia: Síndrome cardiorrenal. Rev Insuf Cardíaca 2007; 4: 175-186.
80. Sultán MG, Osso JNL. ¿Síndrome cardiorrenal o renocardíaco?. Un desafío médico. Parte I. Rev Insuf Cardíaca 2006; 3: 131-135.
81. Duplancic D, Cesarik M, Poljak NK, et al. The inluence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection. Clin Interv in Aging 2013; 8: 149-156.
82. Moe SM, Drüeke TB, Block GA, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney diseasemineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130.
83. Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953.
84. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755-1760.
85. Teng M, Wolf M, Ofsthun MN, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005; 16: 1115-1125.
86. Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4: 1925-1931.
87. Bagshaw SM, George C, Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008; 12 (2): R47. doi: 10.1186/cc6863.
88. Bagshaw SM, Uchino S, Bellomo R, et al. Sepsis acute kidney injury in critically ill patients: clinical characteristics and outcome. Clin J Am Soc Nephrol 2007; 45: 433-439.